Forefront Analytics’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $62.9K | Sell |
|
|||||
|
2025
Q1 | $63.1K | Buy |
|
|||||
|
2024
Q4 | $66.2K | Buy |
|
|||||
|
2024
Q3 | $70.5K | Sell |
|
|||||
|
2024
Q2 | $78.2K | Buy |
|
|||||
|
2024
Q1 | $45.5K | Sell |
|
|||||
|
2023
Q4 | $47.8K | Sell |
|
|||||
|
2023
Q3 | $63.8K | Sell |
|
|||||
|
2023
Q2 | $85.3K | Buy |
|
|||||
|
2023
Q1 | $39.9K | Buy |
|
|||||
|
2022
Q4 | $39.7K | Sell |
|
|||||
|
2022
Q3 | $71K | Buy |
|
|||||
|
2022
Q2 | $67K | Buy |
|
|||||
|
2022
Q1 | $40K | Buy |
|
|||||
|
2021
Q4 | $62K | Buy |
|
|||||
|
2021
Q3 | $68K | Buy |
|